% alzhub.org library filter
% Source: https://alzhub.org/research?category=biomarkers&about=side-effects
% 14 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{shin2021-34620151,
  author  = {Shin, H. Y. and Kim, H. R. and Jahng, G. H. and Jin, C. and Kwon, S. and Cho, S. Y. and Park, S. U. and Jung, W. S. and others},
  title   = {{Efficacy and safety of Kami-guibi-tang for mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled trial}},
  journal = {BMC complementary medicine and therapies},
  year    = {2021},
  doi     = {10.1186/s12906-021-03428-6},
  pmid    = {34620151},
  url     = {https://doi.org/10.1186/s12906-021-03428-6}
}

@article{fleisher2024-38386949,
  author  = {Fleisher, A. S. and Munsie, L. M. and Perahia, D. G. S. and Andersen, S. W. and Higgins, I. A. and Hauck, P. M. and Lo, A. C. and Sims, JR. and others},
  title   = {{Assessment of Efficacy and Safety of Zagotenemab: Results From PERISCOPE-ALZ, a Phase 2 Study in Early Symptomatic Alzheimer Disease}},
  journal = {Neurology},
  year    = {2024},
  doi     = {10.1212/wnl.0000000000208061},
  pmid    = {38386949},
  url     = {https://doi.org/10.1212/wnl.0000000000208061}
}

@article{liu2018-29429971,
  author  = {Liu, E. and Wang, D. and Sperling, R. and Salloway, S. and Fox, N. C. and Blennow, K. and Scheltens, P. and Schmidt, M. E. and others},
  title   = {{Biomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumab}},
  journal = {Neurology},
  year    = {2018},
  doi     = {10.1212/wnl.0000000000005060},
  pmid    = {29429971},
  url     = {https://doi.org/10.1212/wnl.0000000000005060}
}

@article{josephmathurin2022-36151869,
  author  = {Joseph-Mathurin, N. and Llibre-Guerra, J. J. and Li, Y. and McCullough, A. A. and Hofmann, C. and Wojtowicz, J. and Park, E. and Wang, G. and others},
  title   = {{Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease}},
  journal = {Annals of neurology},
  year    = {2022},
  doi     = {10.1002/ana.26511},
  pmid    = {36151869},
  url     = {https://doi.org/10.1002/ana.26511}
}

@article{potter2021-33778150,
  author  = {Potter, H. and Woodcock, J. H. and Boyd, T. D. and Coughlan, C. M. and O'Shaughnessy, JR. and Borges, M. T. and Thaker, A. A. and Raj, B. A. and others},
  title   = {{Safety and efficacy of sargramostim (GM-CSF) in the treatment of Alzheimer's disease}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2021},
  doi     = {10.1002/trc2.12158},
  pmid    = {33778150},
  url     = {https://doi.org/10.1002/trc2.12158}
}

@article{liao2026-41823189,
  author  = {Liao, Wang and Yu, Qun and Chen, Bin and Chen, Hualin and Zou, Liangyu and Xie, Haiqun and Chen, Haobo and Wang, Chenyang and others},
  title   = {{Effectiveness, safety, and biomarker dynamics of lecanemab in Chinese Alzheimer's disease population: a multicenter real-world study}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2026},
  doi     = {10.1002/alz.71231},
  pmid    = {41823189},
  url     = {https://doi.org/10.1002/alz.71231}
}

@article{serranopozo2016-26687817,
  author  = {Serrano-Pozo, A. and Betensky, R. A. and Frosch, M. P. and Hyman, B. T.},
  title   = {{Plaque-Associated Local Toxicity Increases over the Clinical Course of Alzheimer Disease}},
  journal = {The American journal of pathology},
  year    = {2016},
  doi     = {10.1016/j.ajpath.2015.10.010},
  pmid    = {26687817},
  url     = {https://doi.org/10.1016/j.ajpath.2015.10.010}
}

@article{tao2020-31127200,
  author  = {Tao, C. C. and Cheng, K. M. and Ma, Y. L. and Hsu, W. L. and Chen, Y. C. and Fuh, J. L. and Lee, W. J. and Chao, C. C. and others},
  title   = {{Galectin-3 promotes Aβ oligomerization and Aβ toxicity in a mouse model of Alzheimer's disease}},
  journal = {Cell death and differentiation},
  year    = {2020},
  doi     = {10.1038/s41418-019-0348-z},
  pmid    = {31127200},
  url     = {https://doi.org/10.1038/s41418-019-0348-z}
}

@article{lundgaard2018-29396480,
  author  = {Lundgaard, I. and Wang, W. and Eberhardt, A. and Vinitsky, H. S. and Reeves, B. C. and Peng, S. and Lou, N. and Hussain, R. and others},
  title   = {{Beneficial effects of low alcohol exposure, but adverse effects of high alcohol intake on glymphatic function}},
  journal = {Scientific reports},
  year    = {2018},
  doi     = {10.1038/s41598-018-20424-y},
  pmid    = {29396480},
  url     = {https://doi.org/10.1038/s41598-018-20424-y}
}

@article{fu2015-25814669,
  author  = {Fu, W. and Shi, D. and Westaway, D. and Jhamandas, J. H.},
  title   = {{Bioenergetic mechanisms in astrocytes may contribute to amyloid plaque deposition and toxicity}},
  journal = {The Journal of biological chemistry},
  year    = {2015},
  doi     = {10.1074/jbc.m114.618157},
  pmid    = {25814669},
  url     = {https://doi.org/10.1074/jbc.m114.618157}
}

@article{yan2001-11325798,
  author  = {Yan, J. J. and Cho, J. Y. and Kim, H. S. and Kim, K. L. and Jung, J. S. and Huh, S. O. and Suh, H. W. and Kim, Y. H. and others},
  title   = {{Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid}},
  journal = {British journal of pharmacology},
  year    = {2001},
  doi     = {10.1038/sj.bjp.0704047},
  pmid    = {11325798},
  url     = {https://doi.org/10.1038/sj.bjp.0704047}
}

@article{finn2025-41260674,
  author  = {Finn, Quentin and Pascual, Belén and Schulz, Paul E. and Masdeu, Joseph C.},
  title   = {{β-Amyloid PET Signal Reduction in Prior ARIA-E Regions after Antiamyloid Therapy for Alzheimer Disease}},
  journal = {American Journal of Neuroradiology},
  year    = {2025},
  doi     = {10.3174/ajnr.a9111},
  pmid    = {41260674},
  url     = {https://doi.org/10.3174/ajnr.a9111}
}

@article{pauwels2012-22157754,
  author  = {Pauwels, K. and Williams, T. L. and Morris, K. L. and Jonckheere, W. and Vandersteen, A. and Kelly, G. and Schymkowitz, J. and Rousseau, F. and others},
  title   = {{Structural basis for increased toxicity of pathological aβ42:aβ40 ratios in Alzheimer disease}},
  journal = {The Journal of biological chemistry},
  year    = {2012},
  doi     = {10.1074/jbc.m111.264473},
  pmid    = {22157754},
  url     = {https://doi.org/10.1074/jbc.m111.264473}
}

@article{masdeu2026-cc666680,
  author  = {Masdeu, Joseph and Finn, Quentin and Schulz, Paul and Pascual, Belén},
  title   = {{β-amyloid PET Signal Reduction in Regions with ARIA-E Following Anti-amyloid Therapy for Alzheimer Disease (P1-12.010)}},
  journal = {Neurology},
  year    = {2026},
  doi     = {10.1212/wnl.0000000000215645},
  url     = {https://doi.org/10.1212/wnl.0000000000215645}
}